Recent 13F filings reveal that Vanguard has established a massive new position in Hims & Hers Health, Inc. ($HIMS), purchasing approximately 20.9 million shares valued at $679 million. This acquisition represents 9.19% of the $HIMS float, joining a broader trend of institutional "loading up" on the stock. With a reported short interest of 34%, analysts suggest the asset is positioned for a potential short squeeze.